...
首页> 外文期刊>Frontiers in Veterinary Science >Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants
【24h】

Comparison of the Effects of Interleukin-1 on Equine Articular Cartilage Explants and Cocultures of Osteochondral and Synovial Explants

机译:白介素-1对马关节软骨外植体以及软骨和滑膜外植体共培养影响的比较

获取原文

摘要

Osteoarthritis is a ubiquitous disease affecting many horses. The disease causes chronic pain and decreased performance for patients and great cost to owners for diagnosis and treatment. The most common treatments include systemic nonsteroidal anti-inflammatory drugs and intraarticular injection of corticosteroids. There is excellent support for the palliative pain relief these treatments provide, however they do not arrest progression and may in some instances hasten advancement of disease. Orthobiologic treatments have been investigated as potential osteoarthritis treatments that may not only ameliorate pain but also prevent or reverse pathologic articular tissue changes. Clinical protocols for intraarticular use of such treatments have not been optimized; the high cost of in vivo research and concerns over humane use of research animals may be preventing discovery. The objective of this study was to evaluate a novel in vitro articular coculture system for future use in osteoarthritis treatment research. Concentrations and fold increases in various markers of inflammation (prostaglandin E2 and tumor necrosis factor-alpha), degradative enzyme activity (matrix metalloproteinase-13 [MMP-13]), cartilage and bone metabolism (bone alkaline phosphatase and dimethyl-methylene blue), and cell death (lactate dehydrogenase) were compared between IL-1-stimulated equine articular cartilage explant cultures and co-cultures comprised of osteochondral and synovial explants (OCS). Results suggested that there are differences in responses of culture systems to inflammatory stimulation. In particular, the IL-1-induced fold changes in MMP-13 concentration were significantly different between OCS and cartilage explant culture systems after 96 hours. These differences may be relevant to responses of joints to inflammation in vivo and could be important to the biological relevance of in vitro research findings.
机译:骨关节炎是一种普遍存在的疾病,会影响许多马匹。该病会导致慢性疼痛并降低患者的表现,并给所有者带来巨大的诊断和治疗费用。最常见的治疗包括全身性非甾体抗炎药和皮质类固醇的关节内注射。这些疗法可提供姑息性疼痛缓解的出色支持,但是它们不能阻止进展,在某些情况下可能会加速疾病的进展。已经研究了作为可能的骨关节炎治疗的生物疗法,其不仅可以减轻疼痛,而且可以预防或逆转病理性关节组织的变化。关节内使用此类治疗的临床方案尚未优化;体内研究的高成本以及对研究动物的人道使用的担忧可能会阻止发现。这项研究的目的是评估一种新型的体外关节共培养系统,以供将来在骨关节炎治疗研究中使用。炎症的各种标志物(前列腺素E2和肿瘤坏死因子-α),降解酶活性(基质金属蛋白酶13 [MMP-13]),软骨和骨代谢(骨碱性磷酸酶和二甲基-亚甲基蓝)的浓度和倍数增加,比较了IL-1刺激的马关节软骨外植体培养物和由骨软骨和滑膜外植体(OCS)组成的共培养物的细胞死亡和细胞死亡(乳酸脱氢酶)。结果表明,培养系统对炎症刺激的反应存在差异。特别是,在96小时后,OCS和软骨外植体培养系统之间IL-1诱导的MMP-13浓度倍数变化显着不同。这些差异可能与关节对体内炎症的反应有关,并且可能对体外研究结果的生物学相关性很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号